GNH USA

Europe — EMA

Myldroх (Meldonium Dihydrate)

GNH USA supplies Myldroх (Meldonium), a modulator for cardiovascular support in ischemic heart disease and heart failure. Request a quote for supply.

Meldonium Dihydrate

Request sourcing

1
Pack/s

What is Meldonium Dihydrate?

Meldonium, the active ingredient in Myldroх, is a metabolic modulator presented as an oral formulation for oral use. It is used to support cardiovascular function in adults with ischemic heart conditions. GNH USA supplies Myldroх as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Meldonium Dihydrate used for?

Meldonium is used in cardiovascular conditions where myocardial energy metabolism is compromised.

Ischemic heart disease: improves myocardial efficiency and reduces angina episodes. Chronic heart failure: supports cardiac output by enhancing glucose utilization. Peripheral arterial disease: helps alleviate intermittent claudication by improving tissue perfusion.

What are the side effects of Meldonium Dihydrate?

Meldonium may be associated with several adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Headache - Nausea - Dizziness - Insomnia - Gastrointestinal discomfort - Mild hypotension

Serious or Rare Side Effects: - Allergic reactions (rash, angioedema) - Severe hypotension - Cardiac arrhythmia - Elevated liver enzymes - Pancreatitis - Severe skin reactions (Stevens‑Johnson syndrome)

What precautions apply to Meldonium Dihydrate?

When prescribing Meldonium, clinicians should consider specific safety factors.

Renal impairment: adjust use and monitor renal function. Hepatic disease: use with caution, monitor liver enzymes. Concomitant antihypertensives: risk of additive hypotensive effect. Pregnancy and lactation: safety not established; avoid unless benefit outweighs risk. Elderly patients: monitor for increased sensitivity to side effects. Store at below 25°C: keep in original packaging, protect from moisture.

What does Meldonium Dihydrate interact with?

Meldonium can interact with other medicines; awareness of interaction severity is essential.

Major Interactions (Avoid): - Antihypertensive agents: may cause excessive blood pressure reduction. - Other metabolic modulators (e.g., trimetazidine): potential additive cardiac effects. - Drugs affecting carnitine metabolism (e.g., valproic acid): may interfere with Meldonium action.

Moderate Interactions (Monitor Closely): - Diuretics: monitor electrolytes and blood pressure. - Beta‑blockers: observe for bradycardia. - Statins: watch for increased risk of muscle complaints.

Frequently asked questions

What is Myldroх used for?+
Myldroх contains Meldonium, which is employed to support cardiovascular health in conditions such as ischemic heart disease, chronic heart failure, and peripheral arterial disease. By improving myocardial energy metabolism, it helps reduce symptoms like angina and exercise intolerance.
How does Meldonium work?+
Meldonium blocks the synthesis of carnitine, a molecule needed for fatty‑acid transport into mitochondria. This inhibition shifts heart‑muscle energy production from fatty‑acid oxidation toward glucose oxidation, a more oxygen‑efficient pathway, thereby enhancing tolerance to low‑oxygen (ischemic) conditions.
What determines the dosage of Myldroх?+
The appropriate dose of Myldroх is set by the prescribing clinician based on the patient’s specific cardiovascular condition, age, renal and hepatic function, and concomitant therapies. No universal dosing schedule is provided; the prescriber tailors therapy to individual needs.
Is Myldroх safe during pregnancy or breastfeeding?+
Safety data for Meldonium in pregnancy and lactation are limited. Current guidance advises avoiding Myldroх during pregnancy or while breastfeeding unless the potential benefit justifies the potential risk, and only under close medical supervision.
How do I order Myldroх from GNH USA?+
To order Myldroх, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Myldroх compare with other cardiovascular metabolic modulators?+
Myldroх (Meldonium) differs from other modulators such as trimetazidine or ranolazine by specifically inhibiting carnitine synthesis, which directly reduces fatty‑acid oxidation. This unique mechanism may offer distinct benefits in patients where oxygen efficiency is a priority, though comparative effectiveness depends on individual clinical scenarios.
How should Myldroх be stored and handled?+
Store Myldroх at temperatures below 25 °C, in its original packaging, and protect it from moisture and direct sunlight. Avoid exposing the product to high humidity or extreme heat to maintain its stability and potency.
How is Myldroх administered?+
Myldroх is taken orally, typically as a tablet or capsule, with or without food as directed by the prescriber. The exact administration schedule (e.g., once or twice daily) is determined by the treating physician based on therapeutic goals.
What are the most serious risks associated with Myldroх?+
Serious risks, though rare, include severe allergic reactions such as rash or angioedema, marked hypotension, cardiac arrhythmias, and significant liver enzyme elevations. Patients should seek immediate medical attention if they experience symptoms like swelling, difficulty breathing, fainting, or jaundice.
Who should not use Myldroх?+
Myldroх should be avoided in individuals with known hypersensitivity to Meldonium or any excipients, in patients with uncontrolled severe hypotension, and in those where the risk–benefit ratio is unfavorable, such as certain pregnant or lactating women without clear medical justification.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Meldonium Dihydrate
Route
Oral Use
Manufacturer
Grindeks
Origin
EU

Related products

Meldonium Olpha

Meldonium Olpha

Meldonium Dihydrate

Olpha As
EU
Meldonium Olpha

Meldonium Olpha

Meldonium Dihydrate

Olpha As
EU
Meldopharm

Meldopharm

Meldonium Dihydrate

Pharmexon Consulting Sro
EU
Meldopharm

Meldopharm

Meldonium Dihydrate

Pharmexon Consulting Sro
EU